Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | CETP | P11597 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL251555 | 1.00 | CNR1 (0.46) | CNR1ALDH1A1CNR2LPAR1LPAR2 | |
| SCHEMBL170865 | 0.95 | ALDH1A1 (0.54) | CNR1ALDH1A1CNR2 | |
| SCHEMBL945677 | 0.95 | ALDH1A1 (0.54) | CNR1ALDH1A1CNR2 | |
| SCHEMBL251629 | 0.90 | SPHK1 (0.43) | LPAR1LPAR2LPAR3 | |
| SCHEMBL5561906 | 0.90 | SPHK1 (0.43) | LPAR1LPAR2LPAR3 | |
| SCHEMBL27320 | 0.86 | ALDH1A1 (0.43) | CNR1ALDH1A1CNR2LPAR1LPAR2 | |
| SCHEMBL1921025 | 0.82 | ALDH1A1 (0.56) | CNR1ALDH1A1CNR2 | |
| Trimethylammonium SCHEMBL129171 | 0.79 | CNR1 (0.45) | CNR1ALDH1A1CNR2LPAR1LPAR2 | |
| SCHEMBL30442607 | 0.79 | SPHK1 (0.44) | CNR1ALDH1A1CNR2LPAR1LPAR2 | |
| SCHEMBL14834011 | 0.79 | CNR1 (0.47) | CNR1ALDH1A1CNR2LPAR1LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2190 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094668-A | Preparation method and application of lipid nanoparticle | — | 2026-05-26 | — | — | CN | claimed |
| EP-4739652-A1 | LIPIDS AND COMPOSITIONS THEREOF | Kernal Biologics, Inc. (US) | 2026-05-13 | — | — | EP | claimed |
| US-20260116845-A1 | LIPIDS AND COMPOSITIONS THEREOF | KERNAL BIOLOGICS INC (US) | 2026-04-30 | — | — | US | claimed |
| EP-4321504-B1 | PEGYLATED LIPID AND LIPOSOME MODIFIED THEREBY, AND PHARMACEUTICAL COMPOSITION COMPRISING LIPOSOME AND PREPARATION AND USE THEREOF | XIAMEN SINOPEG BIOTECH CO LTD (CN) | 2026-02-18 | — | — | EP | claimed |
| EP-4694913-A2 | LIPID NANOPARTICLES FOR GENE EDITING SYSTEMS | Orthobio Therapeutics, Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4695385-A1 | GENE EDITING FOR INTERVERTEBRAL, INTRA- AND PERIDISCAL THERAPY AND ASSOCIATED SPINAL DISORDERS | Orthobio Therapeutics, Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4695401-A1 | SYNTHETIC CIRCUITS AND USES THEREOF | Strand Therapeutics Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4652281-A2 | GENE EDITING FOR SURGERY-RELATED FIBROSIS TREATMENT | Orthobio Therapeutics, Inc. (US) | 2025-11-26 | — | — | EP | claimed |
| EP-4036079-B1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF AGENTS | MODERNATX INC (US) | 2025-11-19 | — | — | EP | claimed |
| EP-4637838-A1 | LIPID NANOPARTICLE COMPOSITION | Seqirus Inc. (US) | 2025-10-29 | — | — | EP | claimed |
| WO-2017201348-A1 | POLYNUCLEOTIDES ENCODING GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE FOR THE TREATMENT OF GALACTOSEMIA TYPE 1 | MODERNATX, INC. (US) | 2017-11-23 | — | — | WO | claimed |
| WO-2017201349-A1 | POLYNUCLEOTIDES ENCODING CITRIN FOR THE TREATMENT OF CITRULLINEMIA TYPE 2 | MODERNATX, INC. (US) | 2017-11-23 | — | — | WO | claimed |
| WO-2017201347-A1 | POLYNUCLEOTIDES ENCODING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR FOR THE TREATMENT OF CYSTIC FIBROSIS | MODERNATX, INC. (US) | 2017-11-23 | — | — | WO | claimed |
| WO-2017201346-A1 | POLYNUCLEOTIDES ENCODING PORPHOBILINOGEN DEAMINASE FOR THE TREATMENT OF ACUTE INTERMITTENT PORPHYRIA | MODERNATX, INC. (US) | 2017-11-23 | — | — | WO | claimed |
| WO-2017201328-A1 | POLYNUCLEOTIDES ENCODING α-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE | MODERNATX, INC. (US) | 2017-11-23 | — | — | WO | claimed |
| WO-2017201333-A1 | POLYNUCLEOTIDES ENCODING LIPOPROTEIN LIPASE FOR THE TREATMENT OF HYPERLIPIDEMIA | MODERNATX, INC. (US) | 2017-11-23 | — | — | WO | claimed |
| US-20170273907-A1 | STABLE FORMULATIONS OF LIPIDS AND LIPOSOMES | BIONTECH RNA PHARMACEUTICALS GMBH (DE) | 2017-09-28 | — | — | US | claimed |
| WO-2017127750-A1 | MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF | MODERNATX, INC. (US) | 2017-07-27 | — | — | WO | claimed |
| WO-2017112865-A1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF AGENTS | MODERNATX, INC. (US) | 2017-06-29 | — | — | WO | claimed |
| WO-2017049245-A2 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | MODERNATX, INC. (US) | 2017-03-23 | — | — | WO | claimed |